Experimental study of antiepileptic efficacy of thalidomide and its effect on cyclooxygenase-2 and P-glycoprotein in temporal lobe epileptic model rats

ZHANG Qi-zhi,ZHANG Mi,ZENG Han-qing,XU Xue-fei,WANG Fei,LIU Fen,PENG Wen-xing
2014-01-01
Abstract:Objective To study the antiepileptic efficacy of thalidomide and its effect on cyclooxygenase- 2( COX- 2) and P- glycoprotein( P- gp) in temporal lobe epileptic model rats. Methods As a temporal lobe epilepsy( TLE) model,the spontaneous recurrent seizures( SRS) was induced by lithium chloride- pilocarpine in SD rats. Then all the model rats were separated into two groups randomly and thalidomide[10 mg·( kg·day)- 1]was injected intraperitoneally into thalidomide group rats everyday for 7 days. The SRS activities of them were monitored everyday before and during treatment. The expression of COX- 2 and P- gp were measured by immunohistochemistry. Results In thalidomide group, the mean SRS frequency was decreased significantly from( 11. 9 ±4. 5) per rat pre- treatment to( 8. 0 ± 3. 5) during treatment( P 0. 01),and behavioral stage from( 4. 9 ± 0. 1) to( 4. 5 ± 0. 1)( P 0. 05). The expression of P- gp in model group rats was up- regulated significantly compared to that of the healthy group( P 0. 05),and thalidomide tended to reverse the over- expression of P- gp. The expression of COX- 2 was significantly decreased by the thalidomide treatment( P 0. 05). Conclusion Thalidomide displays considerable antiepileptic effect in TLE model rats and it can decrease the expression of COX- 2 significantly. Also,it can partially reverse the over- expression of P- gp.
What problem does this paper attempt to address?